OpenAI & The New York Times
7 shared events · Importance 3 · Last updated Jul 05, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Tech
OpenAI: OpenAI is the developer of ChatGPT and its spokesperson, Drew Pusateri, clarified that their bots are not designed to substitute medical care, highlighting the company's stance on the responsible use of its AI.
The New York Times: The New York Times conducted a survey and published an article on readers' experiences with chatbots for nutrition, contributing to the public discourse on AI in health.
May 26, 2026 · 6 articles
Business
OpenAI: OpenAI is considering delaying its IPO until 2027 to achieve its desired $1 trillion valuation, rather than accepting a lower valuation for an earlier public debut. This decision reflects market uncertainty and government scrutiny over its AI models.
The New York Times: The New York Times reported on OpenAI's deliberations regarding its IPO delay and the reasons behind it, citing sources involved in the company's discussions.
Jun 12, 2026 · 66 articles
NEWSDESK
Explore this relationship live
Track how OpenAI and The New York Times interact across events, view sentiment trends, and discover connected entities.
Open Dashboard